InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,068.47
(
1.15%
)
US TECH 100
16,996.40
(
1.45%
)
Dow Jones
38,485.78
(
0.64%
)
Brent Oil
87.13
(
0.83%
)
Bitcoin
66,616.16
(
-0.36%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pharma_trader

Send PM Follow Ignore
Followers 55
Posts 1664
Boards Moderated 0
Alias Born 12/11/2012

pharma_trader

Re: $heff post# 83146

Wednesday, 09/17/2014 4:41:18 PM

Wednesday, September 17, 2014 4:41:18 PM

Post# of 97237
OXGN-OXiGENE Initiates Phase 2 Study of Fosbretabulin in Gastrointestinal Neuroendocrine Tumors

http://finance.yahoo.com/news/oxigene-initiates-phase-2-study-200100936.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up